| CD19 isoforms enabling resistance to CART-19 immunotherapy are expressed in B-ALL patients at initial diagnosis J Fischer, C Paret, K El Malki, F Alt, A Wingerter, MA Neu, B Kron, ... Journal of Immunotherapy 40 (5), 187-195, 2017 | 217 | 2017 |
| An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling K El Malki, SH Karbach, J Huppert, M Zayoud, S Reißig, R Schüler, ... Journal of Investigative Dermatology 133 (2), 441-451, 2013 | 177 | 2013 |
| Prospective analysis of long-term renal function in survivors of childhood Wilms tumor MA Neu, A Russo, A Wingerter, F Alt, J Theruvath, K El Malki, B Kron, ... Pediatric nephrology 32, 1915-1925, 2017 | 49 | 2017 |
| Benefits of exercise training for children and adolescents undergoing cancer treatment: results from the randomized controlled MUCKI trial S Stössel, MA Neu, A Wingerter, W Bloch, P Zimmer, C Paret, KE Malki, ... Frontiers in Pediatrics 8, 243, 2020 | 46 | 2020 |
| Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy C Paret, J Theruvath, A Russo, B Kron, K El Malki, N Lehmann, ... Oncotarget 7 (50), 83378, 2016 | 35 | 2016 |
| Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy C Paret, A Russo, H Otto, A Mayer, S Zahnreich, W Wagner, D Samuel, ... Oncotarget 8 (69), 114210, 2017 | 29 | 2017 |
| Susceptibility-weighted magnetic resonance imaging of cerebrovascular sequelae after radiotherapy for pediatric brain tumors MA Neu, Y Tanyildizi, A Wingerter, N Henninger, K El Malki, F Alt, B Doerr, ... Radiotherapy and Oncology 127 (2), 280-286, 2018 | 23 | 2018 |
| Subclinical CNS inflammation as response to a myelin antigen in humanized mice M Zayoud, K El Malki, K Frauenknecht, B Trinschek, L Kloos, K Karram, ... Journal of Neuroimmune Pharmacology 8, 1037-1047, 2013 | 21 | 2013 |
| Exploiting gangliosides for the therapy of Ewing’s sarcoma and H3K27M-mutant diffuse midline glioma A Wingerter, K El Malki, R Sandhoff, L Seidmann, DC Wagner, ... Cancers 13 (3), 520, 2021 | 19 | 2021 |
| Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma O Beck, C Paret, A Russo, J Burhenne, M Fresnais, K Steimel, ... Cancers 12 (4), 793, 2020 | 17 | 2020 |
| Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients M Winker, S Stössel, MA Neu, N Lehmann, K El Malki, C Paret, N Joisten, ... Supportive Care in Cancer, 1-4, 2022 | 13 | 2022 |
| Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro-and neuroblastoma J Theruvath, A Russo, B Kron, C Paret, A Wingerter, K El Malki, MA Neu, ... Pediatric hematology and oncology 33 (4), 264-275, 2016 | 9 | 2016 |
| Tumor Lipids of Pediatric Papillary Renal Cell Carcinoma Stimulate Unconventional T Cells N Lehmann, C Paret, K El Malki, A Russo, MA Neu, A Wingerter, ... Frontiers in Immunology 11, 1819, 2020 | 5 | 2020 |
| Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1 C Paret, N Lehmann, H Bender, M Sprang, CJ Sommer, D Cana, ... Cancers 13 (22), 5838, 2021 | 4 | 2021 |
| IL-17 signaling in keratinocytes orchestrates the defense against Staphylococcus aureus skin infection S Moos, T Regen, F Wanke, Y Tian, LT Arendholz, J Hauptmann, ... Journal of Investigative Dermatology 143 (7), 1257-1267. e10, 2023 | 3 | 2023 |
| Glucosylceramide synthase inhibitors induce ceramide accumulation and sensitize H3K27 mutant diffuse midline glioma to irradiation K El Malki, P Wehling, F Alt, R Sandhoff, S Zahnreich, A Ustjanzew, ... International journal of molecular sciences 24 (12), 9905, 2023 | 2 | 2023 |
| Hemophagocytic lymphohistiocytosis in early infancy-pitfall of differentiation between hereditary and infectious reasons A Russo, F Alt, MA Neu, S Eder, A Wingerter, K El Malki, B Lammle, ... Blood 132, 4961, 2018 | 2 | 2018 |
| GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype C Paret, A Ustjanzew, S Ersali, L Seidmann, R Jennemann, N Ziegler, ... Cancers 14 (24), 6051, 2022 | 1 | 2022 |
| Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL N Ziegler, M Cortés-López, F Alt, M Sprang, A Ustjanzew, N Lehmann, ... Oncoimmunology 12 (1), 2184143, 2023 | | 2023 |
| EXPLOITING GLYCOSPHINGOLIPIDS FOR THE CLASSIFICATION AND TREATMENT OF PAEDIATRIC TUMOURS OF THE PERIPHERAL AND CENTRAL NERVOUS SYSTEM C Paret, S Ersali, L Seidmann, A Russo, A Wingerter, K El Malki, ... PEDIATRIC BLOOD & CANCER 70, 2023 | | 2023 |
Morad ZayoudMD. Cancer research center ShebaVerified email at uni-mainz.de
